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There currently is no efficient vaccine that protects
against bovine leukemia virus (BLV) infection. We now
propose a novel approach based on the use of a recombi-
nant live-attenuated BLV provirus. The rationale behind
this strategy relies on the deletion of genes required to
induce pathogenesis maintaining the integrity of those
involved in infectivity. We have identified a BLV attenu-
ated provirus that is infectious but replicates at reduced
levels in cattle. The attenuated strain elicits a strong anti-
BLV immune response and does not spread to uninfected
sentinels maintained during 3 years in the same herd
supporting biosafety of the vaccine. Passive antibodies
are transmitted to newborn calves via maternal colos-
trum and persist during several months. Nevertheless,
the BLV attenuated provirus does not transmit from
cows to calves. Finally, vaccinated animals resist chal-
lenge by a wild-type BLV virus. In summary, we have
identified a safe BLV attenuated provirus with impaired
transmissibility that efficiently protects against infection
in herd conditions.
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